Citation Impact
Citing Papers
The 2017 hormone therapy position statement of The North American Menopause Society
2017
Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines
1998
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients
2009
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Nasopharyngeal carcinoma
2005 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Activators and target genes of Rel/NF-κB transcription factors
1999 Standout
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
1999 Standout
Osteoporosis
2019 Standout
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985: Survival after local recurrence
1993
Breast cancer
2016 Standout
INDUCTION CHEMOTHERAPY IN HEAD AND NECK CANCER
1999
Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.
1998
Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma
2004
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma
2001
Cisplatin resistance in human cancers
1991
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
2003
Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study
2002
Nasopharyngeal carcinoma: A medical oncology viewpoint. The Gustave Roussy experience
1990
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
1998 Standout
Towards Engineering Hormone-Binding Globulins as Drug Delivery Agents
2014
A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy
2000
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
2005
Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study.
1988
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Treatment of head and neck cancer: the role of chemotherapy
1996
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Long-term Survival After Surgical Resection for Recurrent Nasopharyngeal Cancer After Radiotherapy Failure
1991
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer
1995
Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma.
1993
Clinical potential of new antiestrogens.
1997
Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy
2004
Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized Phase III study
1997
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
The Importance of Prognostic Factors in Advanced Prostate Cancer
1990
Nasopharyngeal carcinoma
2015 Standout
Practice parameters for the management of single brain metastasis
2000
Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.
1991
Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma
2000
A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting
2013
Prevention of Venous Thromboembolism
2004 Standout
The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
1998 Standout
Efficacy of radical neck dissection for the control of cervical metastasis after radiotherapy for nasopharyngeal carcinoma
1990
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
The Brief Pain Inventory and Its “Pain At Its Worst in the Last 24 Hours” Item: Clinical Trial Endpoint Considerations
2009
Head and Neck Cancer
1993 Standout
End points for new agents in induction chemotherapy for locally advanced head and neck cancers
2002
Synthesis of new cis-fused tetrahydrochromeno[4,3-b]quinolines and their antiproliferative activity studies against MDA-MB-231 and MCF-7 breast cancer cell lines
2010
Management of malignant pleural effusions
2001 Standout
Chemotherapy for paranasal sinus carcinoma. A 10-year experience at Wayne state university
1988
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Detection of micrometastatic breast cancer by means of real time quantitative RT‐PCR and immunostaining in perioperative blood samples and sentinel nodes
2003
Modern Synthetic Methods for Fluorine‐Substituted Target Molecules
2004 Standout
Laryngeal preservation in head and neck cancer: multidisciplinary approach
2006
Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line
1996 StandoutNobel
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma
2000
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
1990 Standout
Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.
1996
Fractionated Stereotactic Radiotherapy with cis-Platinum Radiosensitization in the Treatment of Recurrent, Progressive, or Persistent Malignant Astrocytoma
1997
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Nasopharyngeal carcinoma: Result of treatment with cis-diamminedichloroplatinum II, 5 fluorouracil, and radiation therapy
1988
Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy
2009
Poly (amino acid) micelle nanocarriers in preclinical and clinical studies
2008
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
2004 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Copper-catalyzed synthesis of β-haloalkenyl chalcogenides by addition of dichalcogenides to internal alkynes and its application to synthesis of (Z)-tamoxifen
2009
Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy
1985
Analysis of Complete Responders after Initial Treatment with Chemotherapy in Head and Neck Cancer
1985
Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG study
1987
Basic Guide to the Mechanisms of Antiestrogen Action
1998
Converting the personalized biomolecular corona of graphene oxide nanoflakes into a high-throughput diagnostic test for early cancer detection
2019
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
2012 Standout
Radiosurgery for malignant meningioma: results in 22 patients
2000 StandoutNobel
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Mechanisms of Estrogen Action
2001 Standout
Transition-Metal-Catalyzed C−S, C−Se, and C−Te Bond Formation via Cross-Coupling and Atom-Economic Addition Reactions
2011 Standout
Carcinoma of the nasopharynx: An analysis of 91 cases and a comparison of differing treatment approaches
1986
Cancer treatment and survivorship statistics, 2016
2016 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Aerobic Copper-Catalyzed Organic Reactions
2013 Standout
Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial
2011
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Results of a Prospective Randomized Trial Comparing Neoadjuvant Chemotherapy Plus Radiotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
2001
Preliminary report of the asian‐oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
1998
Control over overall shape and size in de novo designed proteins
2015 StandoutNobel
Clinical Significance of Circulating Cancer Cells in Peripheral Blood Detected by Reverse Transcriptase-Polymerase Chain Reaction in Patients with Breast Cancer.
2001
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the northern California oncology group
1987
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Selective Estrogen Receptor Modulators: Clinical Spectrum*
1999
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
2015
Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer
1991 Standout
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
2003
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
2015 Standout
Site-dependent response to chemotherapy for carcinoma of the breast.
1985
Adjuvant chemotherapy for advanced nasopharyngeal carcinoma
1987
Neoadjuvant Concurrent Paclitaxel and Radiation in Stage II/III Breast Cancer
2006
Works of David A. Decker being referenced
Computerized bone scan. A potentially useful technique to measure response in prostatic carcinoma
1984
Pilot Study of Combination 5-Fluorouracil, Cisdiamminedichloroplatinum II, and Radiation Therapy for Grade III and IV Astrocytomas
1987
Estrogen replacement therapy in breast cancer survivors: a matched-controlled series
2003
Establishing Mild, Moderate, and Severe Scores for Cancer-Related Symptoms: How Consistent and Clinically Meaningful Are Interference-Based Severity Cut-Points?
2008
Developing a nanoparticle test for prostate cancer scoring
2012
Use of tamoxifen for breast cancer: twenty-eight years later.
1995
Study of Sexual Functioning Determinants in Breast Cancer Survivors
2005
Complete Responders to Chemotherapy in Metastatic Breast Cancer
1979
Detection of circulating epithelial cells after surgery for benign breast disease.
2000
The Significance of a Cytologically Negative Pleural Effusion in Bronchogenic Carcinoma
1978
Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120 hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of head and neck
1984
Acute and Subacute Toxicity Associated with Concurrent Adjuvant Radiation Therapy and Paclitaxel in Primary Breast Cancer Therapy
2002
Chemotherapy for nasopharyngeal carcinoma a ten-year experience
1983
Managing Symptoms Among Patients With Breast Cancer During Chemotherapy: Results of a Two-Arm Behavioral Trial
2008
Brain metastases in patients with renal cell carcinoma: prognosis and treatment.
1984